» Articles » PMID: 33981312

Neurological Symptoms of COVID-19: The Zonulin Hypothesis

Overview
Journal Front Immunol
Date 2021 May 13
PMID 33981312
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

The irruption of SARS-CoV-2 during 2020 has been of pandemic proportions due to its rapid spread and virulence. COVID-19 patients experience respiratory, digestive and neurological symptoms. Distinctive symptom as anosmia, suggests a potential neurotropism of this virus. Amongst the several pathways of entry to the nervous system, we propose an alternative pathway from the infection of the gut, involving Toll-like receptor 4 (TLR4), zonulin, protease-activated receptor 2 (PAR2) and zonulin brain receptor. Possible use of zonulin antagonists could be investigated to attenuate neurological manifestations caused by SARS-CoV-19 infection.

Citing Articles

Pathological Sequelae of SARS-CoV-2: A Review for Clinicians.

Nyarko J, Dogbe P, Ativi L, Wutsika J, Agyenim E, Awere-Duodu A Yale J Biol Med. 2024; 97(4):431-445.

PMID: 39703609 PMC: 11650917. DOI: 10.59249/DQJH2274.


Development and management of gastrointestinal symptoms in long-term COVID-19.

He K, Lei X, Zhang L, Wu D, Li J, Lu L Front Microbiol. 2023; 14:1278479.

PMID: 38156008 PMC: 10752947. DOI: 10.3389/fmicb.2023.1278479.


Potential long-term neurological and gastrointestinal effects of COVID-19: A review of adult cohorts.

Sherif Z, Deverapalli M, Challa S, Martirosyan Z, Whitesell P, Pizuorno A World J Methodol. 2023; 13(4):323-336.

PMID: 37771866 PMC: 10523249. DOI: 10.5662/wjm.v13.i4.323.


Infection, Dysbiosis and Inflammation Interplay in the COVID Era in Children.

Ailioaie L, Ailioaie C, Litscher G Int J Mol Sci. 2023; 24(13).

PMID: 37446047 PMC: 10342011. DOI: 10.3390/ijms241310874.


Increase in gut permeability and oxidized ldl is associated with post-acute sequelae of SARS-CoV-2.

Mouchati C, Durieux J, Zisis S, Labbato D, Rodgers M, Ailstock K Front Immunol. 2023; 14:1182544.

PMID: 37251403 PMC: 10217362. DOI: 10.3389/fimmu.2023.1182544.


References
1.
Noris M, Benigni A, Remuzzi G . The case of complement activation in COVID-19 multiorgan impact. Kidney Int. 2020; 98(2):314-322. PMC: 7246017. DOI: 10.1016/j.kint.2020.05.013. View

2.
Zhu N, Zhang D, Wang W, Li X, Yang B, Song J . A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020; 382(8):727-733. PMC: 7092803. DOI: 10.1056/NEJMoa2001017. View

3.
Zang R, Gomez Castro M, McCune B, Zeng Q, Rothlauf P, Sonnek N . TMPRSS2 and TMPRSS4 promote SARS-CoV-2 infection of human small intestinal enterocytes. Sci Immunol. 2020; 5(47). PMC: 7285829. DOI: 10.1126/sciimmunol.abc3582. View

4.
Rallabhandi P, Nhu Q, Toshchakov V, Piao W, Medvedev A, Hollenberg M . Analysis of proteinase-activated receptor 2 and TLR4 signal transduction: a novel paradigm for receptor cooperativity. J Biol Chem. 2008; 283(36):24314-25. PMC: 2528983. DOI: 10.1074/jbc.M804800200. View

5.
Lee J, Kopetz S, Vilar E, Shen J, Chen K, Maitra A . Relative Abundance of SARS-CoV-2 Entry Genes in the Enterocytes of the Lower Gastrointestinal Tract. Genes (Basel). 2020; 11(6). PMC: 7349178. DOI: 10.3390/genes11060645. View